+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Needle Free Injection System Market Research Report by Technology, by End-user, by Type of Medication, by Usability, by Site of Delivery, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5234018
  • Report
  • July 2021
  • Region: Global
  • 188 Pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Needle Free Injection System Market will Grow to USD 31.77 Billion by 2026, at a CAGR of 11.92%

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Covestro AG
  • Crossject SA
  • Endo International PLC
  • Ferring B.V.
The Global Needle Free Injection System Market size was estimated at USD 16.16 Billion in 2020 and expected to reach USD 18.03 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 11.92% to reach USD 31.77 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Needle Free Injection System to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the Needle Free Injection System Market was studied across Jet-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Spring-Based Needle-Free Injectors, and Vibration-Based Needle-Free Injectors.
  • Based on Product, the Needle Free Injection System Market was studied across Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors.
  • Based on End-user, the Needle Free Injection System Market was studied across Homecare Settings, Hospitals and Clinics, Pharmaceutical and Biotechnology companies, and Research Laboratories.
  • Based on Type of Medication, the Needle Free Injection System Market was studied across Liquid-based needle free injectors, Powder-based needle free injectors, and Projectile/depot-based needle free injectors.
  • Based on Usability, the Needle Free Injection System Market was studied across Disposable Needle-Free Injectors and Reusable Needle-Free Injectors.
  • Based on Site of Delivery, the Needle Free Injection System Market was studied across Intra dermal injectors, Intramuscular injectors, and Subcutaneous injectors.
  • Based on Application, the Needle Free Injection System Market was studied across Insulin Delivery, Oncology, Pain Management, and Vaccine.
  • Based on Region, the Needle Free Injection System Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Needle Free Injection System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Needle Free Injection System Market, including Aijex Pharma International Inc., Amsino International, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Covestro AG, Crossject SA, D'Antonio Consultants International, Inc., Endo International PLC, European Pharma Group B.V., Ferring B.V., Inovio Pharmaceuticals, Inc., Medical International Technology, Inc., PenJet Corporation, PharmaJet, Inc., Portal Instruments, Inc., and Zogenix, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Needle Free Injection System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Needle Free Injection System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Needle Free Injection System Market?
4. What is the competitive strategic window for opportunities in the Global Needle Free Injection System Market?
5. What are the technology trends and regulatory frameworks in the Global Needle Free Injection System Market?
6. What is the market share of the leading vendors in the Global Needle Free Injection System Market?
7. What modes and strategic moves are considered suitable for entering the Global Needle Free Injection System Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Covestro AG
  • Crossject SA
  • Endo International PLC
  • Ferring B.V.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Product Outlook
3.5. End-user Outlook
3.6. Type of Medication Outlook
3.7. Usability Outlook
3.8. Site of Delivery Outlook
3.9. Application Outlook
3.10. Region Outlook
3.11. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic disease and incidence of communicable disease
5.1.1.2. Increasing demand in drug delivery for biosimilars and vaccination
5.1.1.3. Rising demand for self-injection devices
5.1.2. Restraints
5.1.2.1. High development cost of needle-free injection system
5.1.3. Opportunities
5.1.3.1. Growing prevalence and reported cases of diabetes
5.1.3.2. Integration of advance technology
5.1.4. Challenges
5.1.4.1. Stringent regulations associated with devices
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Needle Free Injection System Market, by Technology
6.1. Introduction
6.2. Jet-Based Needle-Free Injectors
6.3. Laser-Powered Needle-Free Injectors
6.4. Spring-Based Needle-Free Injectors
6.5. Vibration-Based Needle-Free Injectors

7. Needle Free Injection System Market, by Product
7.1. Introduction
7.2. Fillable Needle-Free Injectors
7.3. Prefilled Needle-Free Injectors

8. Needle Free Injection System Market, by End-user
8.1. Introduction
8.2. Homecare Settings
8.3. Hospitals and Clinics
8.4. Pharmaceutical and Biotechnology companies
8.5. Research Laboratories

9. Needle Free Injection System Market, by Type of Medication
9.1. Introduction
9.2. Liquid-based needle free injectors
9.3. Powder-based needle free injectors
9.4. Projectile/depot-based needle free injectors

10. Needle Free Injection System Market, by Usability
10.1. Introduction
10.2. Disposable Needle-Free Injectors
10.3. Reusable Needle-Free Injectors

11. Needle Free Injection System Market, by Site of Delivery
11.1. Introduction
11.2. Intra dermal injectors
11.3. Intramuscular injectors
11.4. Subcutaneous injectors

12. Needle Free Injection System Market, by Application
12.1. Introduction
12.2. Insulin Delivery
12.3. Oncology
12.4. Pain Management
12.5. Vaccine

13. Americas Needle Free Injection System Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Needle Free Injection System Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Thailand

15. Europe, Middle East & Africa Needle Free Injection System Market
15.1. Introduction
15.2. France
15.3. Germany
15.4. Italy
15.5. Netherlands
15.6. Qatar
15.7. Russia
15.8. Saudi Arabia
15.9. South Africa
15.10. Spain
15.11. United Arab Emirates
15.12. United Kingdom

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Aijex Pharma International Inc.
17.2. Amsino International, Inc.
17.3. B. Braun Melsungen AG
17.4. Baxter International Inc.
17.5. Becton, Dickinson and Company
17.6. Covestro AG
17.7. Crossject SA
17.8. D'Antonio Consultants International, Inc.
17.9. Endo International PLC
17.10. European Pharma Group B.V.
17.11. Ferring B.V.
17.12. Inovio Pharmaceuticals, Inc.
17.13. Medical International Technology, Inc.
17.14. PenJet Corporation
17.15. PharmaJet, Inc.
17.16. Portal Instruments, Inc.
17.17. Zogenix, Inc.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2020 (USD BILLION)
FIGURE 3. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT , 2020 (USD BILLION)
FIGURE 4. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2020 (USD BILLION)
FIGURE 5. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TYPE OF MEDICATION, 2020 (USD BILLION)
FIGURE 6. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2020 (USD BILLION)
FIGURE 7. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SITE OF DELIVERY, 2020 (USD BILLION)
FIGURE 8. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
FIGURE 9. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 10. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 11. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 14. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD BILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 16. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY JET-BASED NEEDLE-FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY JET-BASED NEEDLE-FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY LASER-POWERED NEEDLE-FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY LASER-POWERED NEEDLE-FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SPRING-BASED NEEDLE-FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SPRING-BASED NEEDLE-FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY VIBRATION-BASED NEEDLE-FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 23. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY VIBRATION-BASED NEEDLE-FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 24. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT , 2020 VS 2026 (%)
FIGURE 25. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT , 2020 VS 2026 (USD BILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT , 2026
FIGURE 27. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY FILLABLE NEEDLE-FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY FILLABLE NEEDLE-FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PREFILLED NEEDLE-FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 30. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PREFILLED NEEDLE-FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 31. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 32. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2020 VS 2026 (USD BILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2026
FIGURE 34. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2026 (USD BILLION)
FIGURE 39. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 40. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2026 (USD BILLION)
FIGURE 41. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 42. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TYPE OF MEDICATION, 2020 VS 2026 (%)
FIGURE 43. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TYPE OF MEDICATION, 2020 VS 2026 (USD BILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TYPE OF MEDICATION, 2026
FIGURE 45. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY LIQUID-BASED NEEDLE FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 46. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY LIQUID-BASED NEEDLE FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 47. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY POWDER-BASED NEEDLE FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 48. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY POWDER-BASED NEEDLE FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 49. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PROJECTILE/DEPOT-BASED NEEDLE FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 50. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PROJECTILE/DEPOT-BASED NEEDLE FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 51. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2020 VS 2026 (%)
FIGURE 52. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2020 VS 2026 (USD BILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2026
FIGURE 54. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY DISPOSABLE NEEDLE-FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 55. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY DISPOSABLE NEEDLE-FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 56. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY REUSABLE NEEDLE-FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 57. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY REUSABLE NEEDLE-FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 58. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SITE OF DELIVERY, 2020 VS 2026 (%)
FIGURE 59. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SITE OF DELIVERY, 2020 VS 2026 (USD BILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SITE OF DELIVERY, 2026
FIGURE 61. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INTRA DERMAL INJECTORS, 2018-2026 (USD BILLION)
FIGURE 62. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INTRA DERMAL INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 63. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INTRAMUSCULAR INJECTORS, 2018-2026 (USD BILLION)
FIGURE 64. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INTRAMUSCULAR INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 65. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SUBCUTANEOUS INJECTORS, 2018-2026 (USD BILLION)
FIGURE 66. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SUBCUTANEOUS INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 67. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 68. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 69. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2026
FIGURE 70. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INSULIN DELIVERY, 2018-2026 (USD BILLION)
FIGURE 71. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 72. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY ONCOLOGY , 2018-2026 (USD BILLION)
FIGURE 73. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY ONCOLOGY , BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 74. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, 2018-2026 (USD BILLION)
FIGURE 75. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 76. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY VACCINE, 2018-2026 (USD BILLION)
FIGURE 77. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY VACCINE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 78. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 79. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 80. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 81. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 82. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 83. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 84. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 85. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 86. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 87. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 88. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 89. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 90. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 91. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 92. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 93. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 94. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 95. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 96. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 97. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 98. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 99. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 100. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 101. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 102. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 103. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 104. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 105. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 106. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 107. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: FPNV POSITIONING MATRIX
FIGURE 108. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 109. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY JET-BASED NEEDLE-FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY LASER-POWERED NEEDLE-FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SPRING-BASED NEEDLE-FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY VIBRATION-BASED NEEDLE-FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT , 2018-2026 (USD BILLION)
TABLE 10. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY FILLABLE NEEDLE-FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PREFILLED NEEDLE-FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TYPE OF MEDICATION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY LIQUID-BASED NEEDLE FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY POWDER-BASED NEEDLE FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PROJECTILE/DEPOT-BASED NEEDLE FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 21. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2026 (USD BILLION)
TABLE 22. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY DISPOSABLE NEEDLE-FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 23. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY REUSABLE NEEDLE-FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 24. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SITE OF DELIVERY, 2018-2026 (USD BILLION)
TABLE 25. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INTRA DERMAL INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 26. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INTRAMUSCULAR INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 27. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SUBCUTANEOUS INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 28. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 29. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2026 (USD BILLION)
TABLE 30. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY ONCOLOGY , BY REGION, 2018-2026 (USD BILLION)
TABLE 31. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2026 (USD BILLION)
TABLE 32. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY VACCINE, BY REGION, 2018-2026 (USD BILLION)
TABLE 33. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 51. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 52. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 53. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 54. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 55. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 56. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 57. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 58. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 59. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 60. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 61. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 62. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: SCORES
TABLE 63. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: BUSINESS STRATEGY
TABLE 64. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 65. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: RANKING
TABLE 66. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 67. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: MERGER & ACQUISITION
TABLE 68. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 69. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 70. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 71. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 72. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Aijex Pharma International Inc.
  • Amsino International, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Covestro AG
  • Crossject SA
  • D'Antonio Consultants International, Inc.
  • Endo International PLC
  • European Pharma Group B.V.
  • Ferring B.V.
  • Inovio Pharmaceuticals, Inc.
  • Medical International Technology, Inc.
  • PenJet Corporation
  • PharmaJet, Inc.
  • Portal Instruments, Inc.
  • Zogenix, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll